Psychosocial predictors of survival in metastatic melanoma.

scientific article published in July 1999

Psychosocial predictors of survival in metastatic melanoma. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1200/JCO.1999.17.7.2256
P698PubMed publication ID10561283

P2093author name stringA S Coates
P N Butow
S M Dunn
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectmetastatic melanomaQ18975855
P304page(s)2256-2263
P577publication date1999-07-01
P1433published inJournal of Clinical OncologyQ400292
P1476titlePsychosocial predictors of survival in metastatic melanoma.
P478volume17

Reverse relations

cites work (P2860)
Q34371938Assessment of patient-reported outcomes in patients with melanoma
Q34021000Associations of social networks with cancer mortality: a meta-analysis.
Q35551141Baseline psychosocial predictors of survival in localised breast cancer
Q38802820Beliefs and practices of patients with advanced cancer: implications for communication
Q47295869COMSKIL Communication Training in Oncology-Adaptation to German Cancer Care Settings
Q47637288Cancer-specific social support received by newly diagnosed cancer patients: validating the new Structural-Functional Social Support Scale (SFSS) measurement tool
Q35925238Communication skills training for oncology professionals
Q40315498Comparison of quality of life among long-term melanoma survivors and non-melanoma controls: a cross-sectional study.
Q58311627Considerations of psychosocial illness phase in cancer survival
Q35126567Coping with melanoma--ten strategies that promote psychological adjustment
Q52165740Coping with metastatic melanoma: the last year of life.
Q43906595Coping with prostate cancer: a quantitative analysis using a new instrument, the centre for clinical excellence in urological research coping with cancer instrument
Q35634135Depression in cancer patients: a critical review
Q55083087Determinants of illness-specific social support and its relation to distress in long-term melanoma survivors.
Q64954576Early quality-of-life and psychological predictors of disease-free time and survival in localized prostate cancer.
Q36703255Endosonographers' approach to delivering a diagnosis of pancreatic cancer: obligated but undertrained
Q35466390Estimating the change in life expectancy after a diagnosis of cancer among the Australian population.
Q40998898Helplessness/hopelessness, minimization and optimism predict survival in women with invasive ovarian cancer: a role for targeted support during initial treatment decision-making?
Q47566992Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer
Q37054958Immunotherapy in the management of melanoma: current status
Q33962394Influence of psychological coping on survival and recurrence in people with cancer: systematic review
Q51020292Lack of marital support and poor psychological responses in male cancer patients.
Q33354210Melanoma survivorship: research opportunities
Q47821844Optimistic expectations and survival after hematopoietic stem cell transplantation
Q53513183Patterns over time in quality of life, coping and psychological adjustment in late stage melanoma patients: an application of multilevel models.
Q47344748Performance status 1 predicts psychological response in female, but not male, ambulatory cancer patients
Q58545234Physician Empathy Interacts with Breaking Bad News in Predicting Lung Cancer and Pleural Mesothelioma Patient Survival: Timing May Be Crucial
Q38673841Potential prognostic value of clinical characteristics, hormone status and major depressive disorder in breast cancer
Q40414575Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort
Q44490957Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer
Q50797247Prospective assessment of the reliability, validity, and sensitivity to change of the Functional Assessment of Cancer Therapy-Melanoma questionnaire.
Q36621564Psychosocial predictors of outcome: time to relapse and survival in patients with early stage melanoma
Q40308580Quality of life as a potential predictor for morbidity and mortality in patients with metastatic hormone-refractory prostate cancer
Q22241762Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008.
Q44509490Quality of life evaluation in a randomised trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients
Q48285831Quality-of-life outcomes in patients with advanced melanoma: A review of the literature
Q36149108Repression: finding our way in the maze of concepts
Q34988141Research design in end-of-life research: state of science
Q43577790Role functioning before start of adjuvant treatment was an independent prognostic factor for survival and time to failure. A report from the Nordic adjuvant interferon trial for patients with high-risk melanoma
Q21144627Social relationships and mortality risk: a meta-analytic review
Q52006060Social support and survival in patients with acute myeloid leukaemia.
Q36891121The PROMIS initiative: involvement of rehabilitation stakeholders in development and examples of applications in rehabilitation research
Q90020797The association between partner bereavement and melanoma: cohort studies in the U.K. and Denmark
Q36393259The effect of psychosocial factors on breast cancer outcome: a systematic review
Q44421258The health-related quality-of-life impact of histamine dihydrochloride plus interleukin-2 compared with interleukin-2 alone in patients with metastatic melanoma.
Q38644501The role of stress and beta-adrenergic system in melanoma: current knowledge and possible therapeutic options
Q49216159When do patient reported quality of life indicators become prognostic in breast cancer?
Q84454010[Psycho-oncological aspects of malignant melanoma. A systematic review from 1990-2008]

Search more.